CompletedPhase 2NCT00023777
S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Studying Acute basophilic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- Thomas R. Chauncey, MD, PhD, MDUniversity of Washington
- Intervention
- filgrastim(biological)
- Enrollment
- 71 enrolled
- Eligibility
- 56 years · All sexes
- Timeline
- 2001 – 2008
Study locations (30)
- MBCCOP - Gulf Coast, Mobile, Alabama, United States
- CCOP - Greater Phoenix, Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States
- Arizona Cancer Center, Tucson, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
- Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
- Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
- CCOP - Bay Area Tumor Institute, Oakland, California, United States
- Chao Family Comprehensive Cancer Center, Orange, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00023777 on ClinicalTrials.govOther trials for Acute basophilic leukemia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT01627041Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNCT00898456Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaAlliance for Clinical Trials in Oncology